{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:29:49Z","timestamp":1787930989041,"version":"build-2784847793"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1124\/dmd.105.006411","type":"journal-article","created":{"date-parts":[[2006,1,14]],"date-time":"2006-01-14T01:45:02Z","timestamp":1137203102000},"page":"570-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["METABOLISM OF THE A1 ADENOSINE RECEPTOR POSITRON EMISSION TOMOGRAPHY LIGAND [18F]8-CYCLOPENTYL-3-(3-FLUOROPROPYL)-1-PROPYLXANTHINE ([18F]CPFPX) IN RODENTS AND HUMANS"],"prefix":"10.1016","volume":"34","author":[{"given":"Dirk","family":"Bier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus H.","family":"Holschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray A.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz H.","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.105.006411_bib1","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S1053-8119(03)00241-6","article-title":"In vivo imaging of adenosine A1 receptors in the human brain with 18F-CPFPX and PET.","volume":"19","author":"Bauer","year":"2003","journal-title":"NeuroImage"},{"key":"10.1124\/dmd.105.006411_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/bmc.490","article-title":"Development of an electrospray ionization mass spectrometric method for the quantification of theophylline in horse serum.","volume":"19","author":"Beaudry","year":"2005","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/dmd.105.006411_bib3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.99.14.1866","article-title":"Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine.","volume":"99","author":"Beugel","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/dmd.105.006411_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0378-4347(00)86080-6","article-title":"Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis.","volume":"226","author":"Blanchard","year":"1981","journal-title":"J Chromatogr"},{"key":"10.1124\/dmd.105.006411_bib5","first-page":"68","article-title":"In vivo biodistribution of the new adenosine A1 receptor (A1AR) antagonist [18F]8-cyclopentyl-1-propyl-3-(3-fluoro-propyl)xanthine ([18F]CPFPX) in healthy primates.","volume":"43","author":"Boy","year":"1998","journal-title":"Drug Dev Res"},{"key":"10.1124\/dmd.105.006411_bib6","first-page":"71","article-title":"Synthesis and characterization of radiolabeled xanthines: new antagonists for the A1 adenosine receptor.","volume":"43","author":"Holschbach","year":"1998","journal-title":"Drug Dev Res"},{"key":"10.1124\/dmd.105.006411_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/jm9705465","article-title":"A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).","volume":"41","author":"Holschbach","year":"1998","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.105.006411_bib8","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/jm020905i","article-title":"Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine ([18F]CPFPX): a potent and selective A1-adenosine receptor antagonist for in vivo imaging.","volume":"45","author":"Holschbach","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.105.006411_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlcr.679","article-title":"Tritium-labelled 8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([H-3]CPFPX), a potent and selective antagonist for the A1 adenosine receptor.","volume":"46","author":"Holschbach","year":"2003","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1124\/dmd.105.006411_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-3565(25)30402-7","article-title":"Theophylline metabolism by the rat liver microsomal system.","volume":"196","author":"Lohmann","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.105.006411_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.CIR.87.4.1169","article-title":"Positron emission tomography with 11C-CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated myocardiopathy.","volume":"87","author":"Merlet","year":"1993","journal-title":"Circulation"},{"key":"10.1124\/dmd.105.006411_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.WCB.0000110531.48786.9D","article-title":"Quantification of cerebral A1 adenosine receptors in the human brain with [18F]CPFPX and PET.","volume":"24","author":"Meyer","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/dmd.105.006411_bib13","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes.","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.105.006411_bib14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/0024-3205(74)90118-0","article-title":"Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction.","volume":"15","author":"Sugiura","year":"1974","journal-title":"Life Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624034494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624034494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.105.006411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:42:36Z","timestamp":1739900556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624034494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0090955624034494"],"URL":"https:\/\/doi.org\/10.1124\/dmd.105.006411","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METABOLISM OF THE A1 ADENOSINE RECEPTOR POSITRON EMISSION TOMOGRAPHY LIGAND [18F]8-CYCLOPENTYL-3-(3-FLUOROPROPYL)-1-PROPYLXANTHINE ([18F]CPFPX) IN RODENTS AND HUMANS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.105.006411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}